How many people are vaccinated in the United States
As of the most recent data from CDC and state reports, hundreds of millions of vaccine doses have been administered in the United States, with the vast majority of adults having received at least one dose and most adults having completed a primary series. Updated boosters have increased protection against severe disease, and coverage varies by age, state, and demographic group. This overview provides current counts, trends over time, and context on how U.S. vaccination levels compare to the population to help clarify the current status of COVID-19 vaccination nationwide.
Key definitions and data sources for U.S. vaccination
Understanding vaccination metrics requires clarity on definitions, data sources, and timing. The core metrics below are consistently reported by CDC, state health departments, and other authoritative dashboards used for public tracking and research.
Definitions and scope
- At least one dose: Anyone who has received a single dose of a COVID-19 vaccine, regardless of completion of a primary series.
- Completed primary series: Typically defined as the number of doses specified by the authorized regimen (e.g., two doses of mRNA or one dose of Janssen) at least two weeks earlier.
- Updated booster: Additional doses recommended to restore protection against newer variants, generally offered to eligible age groups per CDC guidance.
- Fully vaccinated: In common usage, this often means completed primary series; updated guidance sometimes includes a bivalent or latest booster as part of being up to date.
- Data sources and timing: CDC COVID Data Tracker, National Immunization Survey (NIS), CDC National Center for Health Statistics (NCHS), and jurisdictional dashboards. Counts are routinely revised as jurisdictions report corrections; lag times of 1–4 weeks are common.
Current U.S. COVID-19 vaccination coverage
The following table summarizes the most recent available snapshot from national and jurisdictional reporting for the U.S. population. Because vaccination status is updated regularly, use these figures as indicative benchmarks rather than a frozen snapshot.
| Metric | Verified Detail / Estimate | Source Type |
|---|---|---|
| Total doses administered | Over 600 million cumulative doses | CDC COVID Data Tracker, aggregated |
| Population with ≥1 dose (estimated) | Approximately 260 million people | CDC and state-level reports |
| Completed primary series (estimated) | Approximately 230 million people | NIS and CDC age-stratified models |
| At least one updated booster (eligible groups) | Roughly 60–70% of adults 18+ who were eligible | NCHS, CDC age-cohort analysis |
| Fully up to date per latest guidance | Varies by age; generally 65–75%+ among adults 65+, lower in younger adults | CDC age-group surveillance |
Trends over time in U.S. vaccination
Since the initial rollout, U.S. vaccination has evolved from rapid early increases to steady, lower-level additions as immunity wanes and eligibility expands. Early supply constraints and phased eligibility shaped the initial wave; later cycles brought updated formulations and expanded booster access. These trends reflect changing guidance, product availability, public sentiment, and the epidemiological curve of COVID-19. Tracking these patterns helps contextualize current coverage levels and anticipate future phases of the vaccination program.
U.S. vaccination compared to other countries
When placed alongside other high-income nations, the United States demonstrates similarly high initial series coverage and generally stronger updated booster uptake than many peer nations. In global rankings, the U.S. often sits in the upper-middle to top quartile for primary series completion and above average for booster dosing among older adults. However, notable subnational variation exists; coverage and uptake differ meaningfully across states, counties, and demographic strata, which influences population-level resilience to surges and emerging variants.
State and local variation in vaccination rates
Vaccination coverage across U.S. states and territories is uneven. Northeastern states and some Western regions typically report higher series completion, while certain Southern and Midwestern states show lower rates. Urban counties tend to have higher coverage than rural ones, and access to providers, clinic hours, and mobile outreach influence local uptake. Disparities by race, ethnicity, and language access persist despite broad progress, highlighting the importance of targeted, community-based communication and convenient access strategies.
Demographic breakdowns and equity considerations
Age, race and ethnicity, insurance status, and underlying conditions shape who is vaccinated and who remains under-vaccinated. Older adults generally have the highest series completion, while younger adults and some racial and ethnic minority groups have faced barriers related to access, trust, and information. Children’s coverage varies by vaccine type and age group, with adolescent uptake typically trailing younger children. Equity-focused outreach, tailored messaging, and community partnerships remain central to reducing gaps and moving the U.S. closer to broad, durable protection.